![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | A61K 31/4196 | (2006.01) |
A61K 31/46 | (2006.01) | ||
A61P 1/04 | (2006.01) | ||
A61P 1/12 | (2006.01) | ||
A61P 1/18 | (2006.01) | ||
A61P 3/10 | (2006.01) | ||
A61P 9/04 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 11/06 | (2006.01) | ||
A61P 11/08 | (2006.01) | ||
A61P 13/12 | (2006.01) | ||
A61P 15/00 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 27/16 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 31/18 | (2006.01) | ||
A61P 37/00 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
A61P 43/00 | (2006.01) | ||
C07B 53/00 | (2006.01) | ||
C07B 61/00 | (2006.01) | ||
C07C 233/60 | (2006.01) | ||
C07C 233/61 | (2006.01) | ||
C07C 233/63 | (2006.01) | ||
C07D | (2006.01) | ||
C07D 451/04 | (2006.01) |
(11) | Number of the document | 1284974 |
(13) | Kind of document | T |
(96) | European patent application number | 01925808.6 |
Date of filing the European patent application | 2001-05-09 | |
(97) | Date of publication of the European application | 2003-02-26 |
(45) | Date of publication and mention of the grant of the patent | 2004-03-03 |
(46) | Date of publication of the claims translation | 2004-06-25 |
(86) | Number | PCT/IB2001/000806 |
Date | 2001-05-09 |
(87) | Number | WO 2001/090106 |
Date | 2001-11-29 |
(30) | Number | Date | Country code |
0014046 | 2000-05-26 | GB | |
0015835 | 2000-06-27 | GB |
(72) |
PERROS, Manoussos, Pfizer Global R & D, GB
PRICE, David Anthony, Pfizer Global R & D, GB
STAMMEN, Blanda L.C., Pfizer Global R & D, GB
WOOD, Anthony, Pfizer Global R & D, GB
|
(73) |
PHIVCO-1 LLC,,
Corporation Service Company, 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808,
US
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Triazoliltropano dariniai kaip CCR5 moduliatoriai |
TRIAZOLYL TROPANE DERIVATIVES AS CCR5 MODULATORS |
Payment date | Validity (years) | Amount | |
2020-04-29 | 347.00 EUR |